Present and future of influenza prevention in pediatrics

被引:15
作者
Principi, Nicola [1 ]
Esposito, Susanna [1 ]
Marchisio, Paola [1 ]
机构
[1] Univ Milan, Dept Maternal & Pediat Sci, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, I-20122 Milan, Italy
关键词
adjuvants; children; influenza; influenza vaccines; prevention; vaccination; RESPIRATORY-TRACT INFECTIONS; POTENT VACCINE ADJUVANT; ACUTE OTITIS-MEDIA; YOUNG-CHILDREN; ASSESSING IMMUNOGENICITY; ANTIRETROVIRAL THERAPY; UNDERLYING CONDITIONS; ANTIBODY-RESPONSES; HEALTHY-CHILDREN; RANDOMIZED-TRIAL;
D O I
10.1517/14712598.2011.562495
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Introduction: Pediatric influenza not only leads to significant rates of morbidity and an increased risk of hospitalisation, it can also have a substantial socioeconomic impact because children shed larger amounts of viruses over longer periods than adults. This makes adequate prevention desirable, and the best means of reducing the incidence and risks of infection in children is influenza vaccination. Areas covered: The main aim of this review is to analyse the characteristics of new means of influenza prevention and identify which may be important in pediatrics. An updated overview of influenza vaccines is provided, concentrating on strategies of inducing immunogenicity and facilitating the administration of both old and new vaccines. Expert opinion: The currently available data clearly indicate that influenza in children is much less optimally prevented than other vaccine-preventable diseases. A number of different approaches seem to be promising in adults, but there is an urgent need for new strategies when using old vaccines in children or testing new vaccines in pediatric trials.
引用
收藏
页码:641 / 653
页数:13
相关论文
共 90 条
[1]   Epidemiology, complications, and cost of hospitalization in children with laboratory-confirmed influenza infection [J].
Ampofo, Krow ;
Gesteland, Per H. ;
Bender, Jeffery ;
Mills, Michelle ;
Daly, Judy ;
Samore, Matthew ;
Byington, Carrie ;
Pavia, Andrew T. ;
Srivastava, Rajendu .
PEDIATRICS, 2006, 118 (06) :2409-2417
[2]   Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: The importance of cross-protection [J].
Ansaldi, Filippo ;
Canepa, Paola ;
Parodi, Valentina ;
Bacilieri, Sabrina ;
Orsi, Andrea ;
Compagnino, Federica ;
Icardi, Giancarlo ;
Durando, Paolo .
VACCINE, 2009, 27 (25-26) :3345-3348
[3]   Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes [J].
Arkema, A ;
Huckriede, A ;
Schoen, P ;
Wilschut, J ;
Daemen, T .
VACCINE, 2000, 18 (14) :1327-1333
[4]   Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections [J].
Ashkenazi, Shai ;
Vertruyen, Andre ;
Aristegui, Javier ;
Esposito, Susanna ;
McKeith, David Douglas ;
Klemola, Timo ;
Biolek, Jiri ;
Kuehr, Joachim ;
Bujnowski, Tadeusz ;
Desgrandchamps, Daniel ;
Cheng, Sheau-Mei ;
Skinner, Jonathan ;
Gruber, William C. ;
Forrest, Bruce D. .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2006, 25 (10) :870-879
[5]  
Barrett PN, 2010, CURR OPIN MOL THER, V12, P21
[6]   Live attenuated versus inactivated influenza vaccine in infants and young children [J].
Belshe, Robert B. ;
Edwards, Kathryn M. ;
Vesikari, Timo ;
Black, Steven V. ;
Walker, Robert E. ;
Hultquist, Micki ;
Kemble, George ;
Connor, Edward M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07) :685-696
[7]   Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults [J].
Bernstein, David I. ;
Edwards, Kathryn M. ;
Dekker, Cornelia L. ;
Belshe, Robert ;
Talbot, Helen K. B. ;
Graham, Irene L. ;
Noah, Diana L. ;
He, Fenhua ;
Hill, Heather .
JOURNAL OF INFECTIOUS DISEASES, 2008, 197 (05) :667-675
[8]   Influenza-associated deaths among children in the United States, 2003-2004 [J].
Bhat, N ;
Wright, JG ;
Broder, KR ;
Murray, EL ;
Greenberg, ME ;
Glover, MJ ;
Likos, AM ;
Posey, DL ;
Klimov, A ;
Lindstrom, SE ;
Balish, A ;
Medina, MJ ;
Wallis, TR ;
Guarner, J ;
Paddock, CD ;
Shieh, WJ ;
Zaki, SR ;
Sejvar, JJ ;
Shay, DK ;
Harper, SA ;
Cox, NJ ;
Fukuda, K ;
Uyeki, TM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (24) :2559-2567
[9]   Safety of MF59-adjuvanted versus non-adjuvanted influenza vaccines in children and adolescents: An integrated analysis [J].
Black, Steven ;
Della Cioppa, Giovanni ;
Malfroot, Anne ;
Nacci, Pantaleo ;
Nicolay, Uwe ;
Pellegrini, Michele ;
Sokal, Etienne ;
Vertruyen, Andre .
VACCINE, 2010, 28 (45) :7331-7336
[10]   Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial [J].
Bresson, Jean-Louis ;
Perronne, Christian ;
Launay, Odile ;
Gerdil, Catherine ;
Saville, Melanie ;
Wood, John ;
Hoeschler, Katja ;
Zambon, Maria C. .
LANCET, 2006, 367 (9523) :1657-1664